Fulgent Genetics is transforming into a healthcare company with a focus on oncology, presenting a promising opportunity. Read ...

Researchers have not only found a dream switch but may have figured out how to flip it, potentially transforming sleep medicine as we know it.

Bluebird Bio (BLUE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

More young people are ditching college for the workforce than ever before. If energized, they could play a major role in the ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bluebird Bio (BLUE – Research Report), ...